Most notably behind are the advisory panels for Rare Disease, Clinical Trials, and Communication and Dissemination. Dr. Selby reported that the slates for the Rare Disease and Clinical Trials panels will be presented by the end of the quarter. The slate for the Communication and Dissemination panel will be presented to the Board in September.
The Board asked that the next Dashboard include targets for each of the goals displayed, but otherwise stated they were extremely satisfied with the document.
Dr. Selby also noted that PCORI will be switching from a calendar year (CY) to fiscal year (FY) reporting structure.